Patent classifications
A61K51/084
LABELED OXYTOCIN AND METHOD OF MANUFACTURE AND USE
Disclosed are .sup.13N-oxytocin molecules, methods of manufacture of .sup.13N-oxytocin molecules and methods of use of .sup.13N-oxytocin molecules in the determination of the distribution and kinetics of .sup.13N-oxytocin molecules after craniofacial or other application methods.
Vinylsulfone-based 18F-labeling compositions and methods and uses thereof
A thio-selective radioactive labeling agent has the following general formula:
*R-L-VS, wherein said *R is a radioisotope, L is a linking group, and VS is a vinylsulfone functional group.
Labeled oxytocin and method of manufacture and use
Disclosed are .sup.13N-oxytocin molecules, methods of manufacture of .sup.13N-oxytocin molecules and methods of use of .sup.13N-oxytocin molecules in the determination of the distribution and kinetics of .sup.13N-oxytocin molecules after craniofacial or other application methods.
MAGNESIUM-CONTAINING OXYTOCIN FORMULATIONS AND METHODS OF USE
Disclosed are methods and compositions for the treatment of autism spectrum disorder, related disorders and symptoms of such disorders, comprising co-administration of an oxytocin peptide and magnesium ions. Co-administration of an oxytocin peptide and magnesium ions results in a synergistic or enhanced effect on reducing social and communication deficits in a patient suffering from an autism spectrum disorder.
MAGNESIUM-CONTAINING OXYTOCIN FORMULATIONS AND METHODS OF USE
Disclosed are methods and compositions for the treatment of autism spectrum disorder, related disorders and symptoms of such disorders, comprising co-administration of an oxytocin peptide and magnesium ions. Co-administration of an oxytocin peptide and magnesium ions results in a synergistic or enhanced effect on reducing social and communication deficits in a patient suffering from an autism spectrum disorder.
LABELED OXYTOCIN AND METHOD OF MANUFACTURE AND USE
Disclosed are .sup.13N-oxytocin molecules, methods of manufacture of .sup.13N-oxytocin molecules and methods of use of .sup.13N-oxytocin molecules in the determination of the distribution and kinetics of .sup.13N-oxytocin molecules after craniofacial or other application methods.
Labeled oxytocin and method of manufacture and use
Disclosed are .sup.13N-oxytocin molecules, methods of manufacture of .sup.13N-oxytocin molecules and methods of use of .sup.13N-oxytocin molecules in the determination of the distribution and kinetics of .sup.13N-oxytocin molecules after craniofacial or other application methods.